Australis Responds To Green Therapeutics, Meridian Lawsuit
Australis Capital (CSE: AUSA) has publicly responded to the previously announced lawsuits from Green Therapeutics and Meridian Companies for breach
Read more
Australis Capital Inc
Australis Capital Sees Green Therapeutics, Meridian File Lawsuit For Breach of Contract
It’s been a rough week for Australis Capital (CSE: AUSA). Following the public grievance issued last Friday by shareholder Roger
Read more
Australis Capital Sees Shareholder Issue Statement Condemning Passport Transaction
Australis Capital (CSE: AUSA) has seen a shareholder go head-to-head with the company over the announcement yesterday that the company
Read more
Folium Bioscience Sees SEC Inquiry Following Failed Australis Merger
Following a failed merger with that of Australis Capital Inc (CSE: AUSA), it appears that an SEC inquiry has begun
Read more
Australis Terminates Folium Biosciences Merger
Australis Capital (CSE: AUSA) has cancelled its previously proposed merger with that of Folium Biosciences as a result of new
Read more
Australis Capital Enters Into LOI to Acquire Paytron
Australis Capital Inc (CSE: AUSA) has successfully entered into a letter of intent to purchase the entirety of Paytron LLC.
Read more